Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of
reproductive age, with a prevalence of up to 10%. Various diagnostic criteria have been …

BACKGROUND In women, anti-Müllerian hormone (AMH) levels may represent the ovarian
follicular pool and could be a useful marker of ovarian reserve. The clinical application of …

Polycystic ovary syndrome (PCOS) affects 8–13% of women. The Rotterdam diagnostic
criteria include polycystic ovarian morphology (PCOM) on ultrasound, but given recognized …

Accumulating evidence from animal and human studies indicates a role for vitamin D in
female reproductive physiology, and numerous clinical studies have suggested its potential …

OBJECTIVE: To determine age-specific serum anti-Müllerian hormone (AMH) values for
women presenting to US fertility clinics. DESIGN: Retrospective study. SETTING: Single …

OBJECTIVE: To reevaluate ovarian hyperstimulation syndrome (OHSS) prevention
techniques and provide a classification system for grading OHSS and evidence-based …

Objective To determine the association between ovarian reserve biomarkers and future
fertility among late reproductive-age women. Design Cohort study of participants enrolled in …

Objective To assess whether antimüllerian hormone (AMH) is a predictor of implantation
and/or clinical pregnancy in women undergoing assisted reproductive technology. Design …

Objective To evaluate the effects of laparoscopic cystectomy on ovarian reserve in patients
with endometriomas. Design Prospective study. Setting Private and university hospitals …

Objective Serum Antimüllerian hormone (AMH) levels are elevated in polycystic ovarian
syndrome and have been shown to be useful in its diagnosis. However, the clinical …